Third Quarter 2026
Filed Nov 3, 2026WEIS MARKETS REPORTS THIRD QUARTER 2026 RESULTS
Third-quarter total revenue increased 3.0%, gross profit increased 5.8%, income from operations increased 38.6%, and net income increased 31.4%, while comparable store sales excluding fuel decreased 1.2%.
Key metrics
shortened, hover for the filing’s print| Metric | Value | q/q | y/y |
|---|---|---|---|
| 13 Weeks Ended September 26, 2026 - Net salesGAAP | $1.27B | – | – |
| 13 Weeks Ended September 26, 2026 - Other revenueGAAP | $4.27M | – | – |
| 13 Weeks Ended September 26, 2026 - Total revenueGAAP | $1.28B | – | 3.0% |
| 13 Weeks Ended September 26, 2026 - Cost of sales, including advertising, warehousing and distribution expensesGAAP | $954.5M | – | – |
| 13 Weeks Ended September 26, 2026 - Gross profit on salesGAAP | $324.6M | – | 5.8% |
| 13 Weeks Ended September 26, 2026 - Gross profit marginGAAP | 25.5% | – | – |
| 13 Weeks Ended September 26, 2026 - Operating, general and administrative expensesGAAP | $296.1M | – | – |
| 13 Weeks Ended September 26, 2026 - Income from operationsGAAP | $28.50M | – | 38.6% |
| 13 Weeks Ended September 26, 2026 - Investment income (loss) and interest expenseGAAP | $2.09M | – | – |
| 13 Weeks Ended September 26, 2026 - Other income (expense)GAAP | $ (460) | – | – |
| 13 Weeks Ended September 26, 2026 - Income before provision for income taxesGAAP | $30.13M | – | – |
| 13 Weeks Ended September 26, 2026 - Provision for income taxesGAAP | $7.92M | – | – |
| 13 Weeks Ended September 26, 2026 - Net incomeGAAP | $22.21M | – | 31.4% |
| 13 Weeks Ended September 26, 2026 - Weighted-average shares outstanding, basic and dilutedGAAP | 24,744,597 | – | – |
| 13 Weeks Ended September 26, 2026 - Cash dividends per shareGAAP | $ 0.34 | – | – |
| 13 Weeks Ended September 26, 2026 - Basic and diluted earnings per shareGAAP | $ 0.90 | – | – |
| 13 Weeks Ended September 26, 2026 - Comparable store sales (individual year)GAAP | 1.3 % | – | 1.3 % |
| 13 Weeks Ended September 26, 2026 - Comparable store sales (two-year stacked)non-GAAP | 3.8 | – | – |
| 13 Weeks Ended September 26, 2026 - Comparable store sales, excluding fuel (individual year)GAAP | (1.2) | – | (1.2) |
| 13 Weeks Ended September 26, 2026 - Comparable store sales, excluding fuel (two-year stacked)non-GAAP | 1.3 % | – | – |
| 39 Weeks Ended September 26, 2026 - Net salesGAAP | $3.80B | – | – |
| 39 Weeks Ended September 26, 2026 - Other revenueGAAP | $12.91M | – | – |
| 39 Weeks Ended September 26, 2026 - Total revenueGAAP | $3.81B | – | 4.1% |
| 39 Weeks Ended September 26, 2026 - Cost of sales, including advertising, warehousing and distribution expensesGAAP | $2.83B | – | – |
| 39 Weeks Ended September 26, 2026 - Gross profit on salesGAAP | $983.3M | – | 7.8% |
| 39 Weeks Ended September 26, 2026 - Gross profit marginGAAP | 25.9% | – | – |
| 39 Weeks Ended September 26, 2026 - Operating, general and administrative expensesGAAP | $889.9M | – | – |
| 39 Weeks Ended September 26, 2026 - Income from operationsGAAP | $93.31M | – | 28.6% |
| 39 Weeks Ended September 26, 2026 - Investment income (loss) and interest expenseGAAP | $7.38M | – | – |
| 39 Weeks Ended September 26, 2026 - Other income (expense)GAAP | −$2.53M | – | – |
| 39 Weeks Ended September 26, 2026 - Income before provision for income taxesGAAP | $98.17M | – | – |
| 39 Weeks Ended September 26, 2026 - Provision for income taxesGAAP | $25.25M | – | – |
| 39 Weeks Ended September 26, 2026 - Net incomeGAAP | $72.92M | – | 18.1% |
| 39 Weeks Ended September 26, 2026 - Weighted-average shares outstanding, basic and dilutedGAAP | 24,744,597 | – | – |
| 39 Weeks Ended September 26, 2026 - Cash dividends per shareGAAP | $ 1.02 | – | – |
| 39 Weeks Ended September 26, 2026 - Basic and diluted earnings per shareGAAP | $ 2.95 | – | – |
| 39 Weeks Ended September 26, 2026 - Comparable store sales (individual year)GAAP | 1.9 % | – | 1.9 % |
| 39 Weeks Ended September 26, 2026 - Comparable store sales (two-year stacked)non-GAAP | 3.6 | – | – |
| 39 Weeks Ended September 26, 2026 - Comparable store sales, excluding fuel (individual year)GAAP | (0.1) | – | (0.1) |
| 39 Weeks Ended September 26, 2026 - Comparable store sales, excluding fuel (two-year stacked)non-GAAP | 1.8 % | – | – |
Capital returns
- On October 29, 2026, the Board of Directors declared a quarterly cash dividend of $0.34 per share, payable on November 23, 2026, to shareholders of record as of November 9, 2026.
What drove it
- Higher fuel sales, reflecting both retail price inflation and increased gallons sold, supported total revenue growth.
- Sales from new stores supported revenue growth.
- Improved store inventory shrink performance and lower costs within the internal supply chain helped drive higher gross profit margin.
- The Company cited people, process and technology investments across stores, supply chain, manufacturing and the Store Support Center.
- Third-quarter pharmacy sales were negatively impacted by approximately $14.56 million from Inflation Reduction Act Medicare maximum fair price provisions, reducing total revenue growth by approximately 1.2 percentage points.
- Year-to-date pharmacy sales were negatively impacted by approximately $32.75 million from Inflation Reduction Act Medicare maximum fair price provisions, reducing total revenue growth by approximately 0.9 percentage points.
Concerns
- Customers remained cautious with their spending and continued to seek affordability and value.
- Comparable store sales excluding fuel decreased 1.2% in the third quarter and decreased 0.1% year to date.
- Lower overall sales in pharmacy, dairy and produce partially offset third-quarter revenue growth.
- Dairy sales reflected lower egg pricing compared with the prior year.
- Produce sales were negatively affected by lower customer demand during the Cyclospora outbreak in the third quarter.
- Lower investment income and a higher effective income tax rate moderated net-income growth.
What to watch
- Comparable store sales excluding fuel following the third-quarter decrease of 1.2%.
- The continuing effect of Inflation Reduction Act Medicare maximum fair price provisions on pharmacy sales.
- Fuel sales, including retail price inflation and gallons sold.
- The persistence of gross-profit benefits from store inventory shrink performance and internal supply-chain costs.
- Dairy egg pricing and produce demand following the Cyclospora outbreak.
Analysis
Weis Markets reported a stronger 13-week third quarter ended September 26, 2026. Total revenue was $1.28 billion, up 3.0%, while gross profit increased 5.8% to $324.61 million and income from operations increased 38.6% to $28.51 million. Net income was $22.21 million, up 31.4%, and basic and diluted earnings per share were $0.90 compared with $0.69 per share in the same period in 2025.
Revenue growth was supported primarily by higher fuel sales and sales from new stores. Comparable store sales increased 1.3%, but comparable store sales excluding fuel decreased 1.2%, indicating that fuel was an important contributor to the reported top-line increase. The Company identified lower sales in pharmacy, dairy and produce as offsets. Pharmacy pricing headwinds related to Inflation Reduction Act Medicare maximum fair price provisions negatively affected third-quarter pharmacy sales by approximately $14.56 million and reduced total revenue growth by approximately 1.2 percentage points.
Profitability improved more rapidly than revenue. Gross profit margin increased to 25.5% from 24.8%, which management attributed to improved store inventory shrink performance and lower costs within the internal supply chain. Operating, general and administrative expenses were $296,109, compared with $286,313 in the prior-year quarter, while the improvement in gross profit supported the increase in income from operations. Lower investment income and a higher effective income tax rate moderated the earnings benefit below operating income.
For the 39-week year-to-date period, total revenue was $3.81 billion, up 4.1%, gross profit increased 7.8% to $983.26 million, and gross profit margin increased to 25.9% from 25.0%. Income from operations increased 28.6% to $93.31 million, while net income increased 18.1% to $72.92 million and earnings per share totaled $2.95. Year-to-date comparable store sales increased 1.9%, but comparable store sales excluding fuel decreased 0.1%.
Capital returns were limited in the release to the declared quarterly cash dividend of $0.34 per share. The filing provided no forward financial outlook, cash-flow figures, cash balance, debt balance, or share-repurchase disclosure. Near-term attention centers on fuel-supported sales, pharmacy pricing pressure, non-fuel comparable-store sales, dairy egg pricing, and produce demand following the Cyclospora outbreak.
Management, verbatim
In the third quarter we delivered higher total revenue and improved earnings while customers remained cautious with their spending and continued to seek affordability and value.
Jonathan H. Weis, Chairman, President and CEO
Improved store inventory shrink performance and lower costs within our internal supply chain helped drive a higher gross profit margin.
Jonathan H. Weis, Chairman, President and CEO
Not in the filing
stated, not guessed- Forward revenue guidance
- Forward gross-margin guidance
- Forward operating-expense guidance
- Forward tax-rate guidance
- Prior guidance for comparison
- Cash balance
- Debt balance
- Operating cash flow
- Free cash flow
- Capital expenditures
- Share repurchases
- Segment revenue disclosures
- Segment profit disclosures
- Effective income tax rate
- Non-GAAP earnings measures other than two-year stacked comparable store sales
Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.